A case-control study of risk factors for hepatocellular carcinoma in Henan, China

American Journal of Tropical Medicine and Hygiene

Volumn 59, Issue 6, 1998, Pages 947-951

  Zhang, Jian Ying ^a   Wang, Xiao ^a   Han, Sheng Gao ^b   Zhuang, Hui ^c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; ARACHIS OIL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; CORN; FAMILIAL DISEASE; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PEANUT;

ARACHIS; ARACHIS HYPOGAEA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; ZEA MAYS;

EID: 0032444925     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.59.947     Document Type: Article

References (20)

1. Parkin D, Pisani P, Ferlay J, 1993. Estmates of the worldwide incidence of 18 major cancers in 1985. Int J Cancer 54: 594-606.
2. Simonetti RG. Camma C, Fiorello F, Politi F, D'Amico G, Pagliaro L, 1991. Hepatocellular carcinoma: a worldwide problem and the major risk factors. Dig Dis Sci 36: 962-972.
3. Yen FS, Shen KN, 1986. Epidemiology and early diagnosis of primary liver cancer in China. Adv Cancer Res 47: 297-329.
4. Zhang JY, 1995. The research progress of the relationship between hepatitis B, C infection and hepatocellular carcinoma. Zhana JY, Zheng PY, Zhang Y, eds. Research and Practice in Viral Liver Diseases. Beijing, China: Chinese Science and Technology Press, 148-167.
5. Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, Lin ZY, Tsai JH, 1997. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br J Cancer 76: 968-974.
6. Yu H, Harris RE, Kabat GC, Wynder EL, 1988. Cigarette smoking, alcohol consumption and primary liver cancer: a case-control study in the USA. Int J Cancer 42: 325-328.
7. Tsukuma H, Hiyama T, Oshima A, Sobue T, Fujimoto I, Kasugal H, Kojima I, Sasaki Y, Imaoka S, Horiuchi N, Okuda S, 1990. A case-control study of hepatocellular carcinoma in Osaka, Japan. Int J Cancer 45: 231-236.
8. Mayans MV, Calvet X, Bruix J, Bruguera M, Costa J, Esteve J, Bosch FX, Bru C, Rodes J, 1990. Risk factors for hepatocellular carcinoma in Catalonia, Spain. Int J Cancer 46: 378-381.
9. Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H, 1998. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma (HCC) in Henan, China. Int J Epidemiol 27: 574-578.
10. Srivatanakul P, Parkin DM, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, Wild CP, 1991. Liver cancer in Thailand. II. A case-control study of hepatocellular carcinoma. Int J Cancer 48: 329-332.
11. Yu MC, Mack T, Hanisch R, Peters RL, Henderson BE, Pike MC, 1983. Hepatitis, alcohol consumption, cigarette smoking, and hepatocellular carcinoma in Los Angeles. Cancer Res 43: 6077-6079.
12. Tanaka T, Hirohata T, Takeshita S, Hirohata I, Koga S, Sugimachi K, Kanematsu K, Ohryohji F, Ishibashi H, 1992. Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer 51: 509-514.
13. Oshima A, Tsukuma H, Hiyama T, Fujimoto I, Yamano H, Tanaka M, 1984. Follow-up study of HBsAg-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int J Cancer 34: 775-779.
14. Kew MC, Di Bisceglie AM, Paterson AC, 1985. Smoking as a risk factor in hepatocellular carcinoma: a case-control study in southern African Blacks. Cancer 56: 2315-2317.
15. London WT, Evans AA, McGlynn K, Buetow K, An P, Gao LL, Lustbader E, ROSS E, Chen GC, Shen FM, 1995. Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen city, China. Intervirology 38: 155-161.
16. Van Renshurg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van Der Watt JJ, Vincent TJ, Purchase IF, 1985. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 51: 713-726.
17. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD, 1994. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3: 3-10.
18. Soini Y, Chia SC, Bennett WP, Groopman JD, Wang JS, DeBenedetti VMG, Cawley H, Welsh JA, Hansen C, Beruasa NV, Jones EA, DiBiseeglie AM, Trivers GE, Sandoval CA, Calderon IE, Munoz Espinosa LE, Harris CC, 1996. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Carcinogenesis 17: 1007-1012.
19. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, Henderson BE, 1992. Urinary afla-toxin biomarkers and risk of hepatocellular carcinoma. Lancet 339: 943-946.
20. Wang LY, Hatch M, Chen CJ, Levin B, You SL, Lu SN, Wu NM, Wu WP, Wang LW, Wana Q, Huang GT, Yang PM, Lee HS, Santella RM, 1996. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer 67: 620-625.